Back

ST Pharm signs record $66.135 million oligonucleotide API supply contract

Verifying
  • ST Pharm signed an oligonucleotide API supply agreement with a U.S.-based global biotech company.
  • $66.135 million contract equals about 91.3 billion won and 27.5% of last year's revenue.
  • ST Pharm's disclosed oligonucleotide API orders this year total about 263.5 billion won.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.